Brochure report showcasing the three types of Infantile Hemangioma, the evolution of the disease, and the sequelae after involution of untreated hemangiomas.
Brochure discussing the indications, contraindications, how to prescribe, how to administer, duration of treatment, product characteristics, and more for HEMANGEOL.
DOSING ERRORS FOR HEMANGEOL VS GENERIC PROPRANOLOL HYDROCHLORIDE
In a 2017, the Journal of American Academy of Dermatology published a letter to the editor, “Prescribing propranolol for infantile hemangioma: Assessment of dosing errors,” showing results from an institutional review board-approved survey comparing the propensity for dispensing and dosing calculation errors of HEMANGEOL (propranolol hydrochloride oral solution 4.28 mg/mL) versus generic propranolol hydrochloride oral solutions (4 mg/mL and 8 mg/mL) during the treatment of infantile hemangiomas.
The survey of 220 pediatric dermatologists and other physicians who treat infantile hemangioma found that medication dispensing and calculation errors are very common among physicians prescribing generic propranolol hydrochloride vs. HEMANGEOL.
When a baby first develops an infantile hemangioma, parents and caregivers may experience feelings of confusion, anxiousness, and guilt.
Below is a list of organizations dedicated to providing education and support to all those affected by infantile hemangiomas.
The Vascular Birthmarks Foundation (VBF) P.O. Box 106 Latham, NY 12110-0106 Phone: (877) 823-4646 Website:birthmark
The Vascular Birthmarks Foundation is an international charitable organization that connects families affected by vascular birthmarks, tumors, or syndromes to the appropriate medical professionals. The foundation also provides informational resources, sponsors physician education, facilitates medical mission trips, and supports research and programs that promote acceptance for individuals with birthmarks.
HEMANGEOL 
Derm Expert
